» Articles » PMID: 36614213

MicroRNAs Are Abundant and Stable in Platelet-Rich Fibrin and Other Autologous Blood Products of Canines

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2023 Jan 8
PMID 36614213
Authors
Affiliations
Soon will be listed here.
Abstract

Various microRNAs (miRNAs) present in autologous blood products of canines have not been studied recently. We aimed to elucidate the existence of miRNAs in platelet-rich fibrin (PRF) and the stability of canine autologous blood products under various storage conditions. Total RNAs were isolated from PRF and other autologous blood products following newly adapted protocols used in commercial kits for plasma and tissue samples. Quantitative real-time polymerase chain reaction analysis (qPCR) was used to detect miRNAs in autologous blood products. The miR-16, miR-21, miR-155, and miR-146a were abundant in PRF and other autologous blood products of canines. Furthermore, we found they could maintain stability under protracted freezing temperatures of -30 °C for at least one month. Our findings revealed that PRF might be a stable resource for various canine miRNAs.

References
1.
Kargarpour Z, Nasirzade J, Panahipour L, Miron R, Gruber R . Platelet-Rich Fibrin Decreases the Inflammatory Response of Mesenchymal Cells. Int J Mol Sci. 2021; 22(21). PMC: 8583104. DOI: 10.3390/ijms222111333. View

2.
Kaur S, Abu-Shahba A, Paananen R, Hongisto H, Hiidenmaa H, Skottman H . Small non-coding RNA landscape of extracellular vesicles from human stem cells. Sci Rep. 2018; 8(1):15503. PMC: 6195565. DOI: 10.1038/s41598-018-33899-6. View

3.
Schmittgen T, Livak K . Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008; 3(6):1101-8. DOI: 10.1038/nprot.2008.73. View

4.
Wang X, Zhang Y, Choukroun J, Ghanaati S, Miron R . Behavior of Gingival Fibroblasts on Titanium Implant Surfaces in Combination with either Injectable-PRF or PRP. Int J Mol Sci. 2017; 18(2). PMC: 5343867. DOI: 10.3390/ijms18020331. View

5.
Song Y, Dou H, Li X, Zhao X, Li Y, Liu D . Exosomal miR-146a Contributes to the Enhanced Therapeutic Efficacy of Interleukin-1β-Primed Mesenchymal Stem Cells Against Sepsis. Stem Cells. 2017; 35(5):1208-1221. DOI: 10.1002/stem.2564. View